Skip to main content
. 2023 Jun 5;109(8):2185–2195. doi: 10.1097/JS9.0000000000000471

Table 2.

Outcomes study population and specific treatment groups, data represented as n (%), mean (SD), and median [minimum–maximum].

Diagnosis ASBO at discharge, N=382
Total, N=510 ASBO, N=382 (74.9%) Definitive NOM, N=192 (50.3%) Emergency surgery, N=71 (18.6%) Delayed surgery, N=119 (31.1%) Sig. P
LOS (day) 5 (11.01) 8.41 (11.19) 3 [0–36] 7 [0–52] 11 [2–129] <0.001
In-hospital mortality 16 (3.1) 12 (3.1) 3 (1.6) 4 (5.6) 5 (4.2) 0.177
ICU admission 52 (10.2) 43 (11.3) 2 (1.0) 15 (21.1) 26 (21.8) <0.001
 Duration (days) 1.00 [1–35] 1.00 [1–35] 2.5 [1–4] 2.00 [1–11] 1.00 [1–35] 0.540
 Readmission 78 (15.3) 56 (14.7) 33 (17.2) 11 (15.5) 12 (10.1) 0.256
 Recurrence 54 (10.6) 38 (9.9) 30 (15.6) 4 (5.6) 4 (2.4) <0.001
 Complications 24 (4.7) 18 (4.7) 3 (1.6) 7 (9.9) 8 (6.7)

ASBO, adhesive small bowel obstruction; ICU, intensive care unit; LOS, length of stay; NOM, nonoperative management.